Agenda

of the 4th International Practical Research Conference: Hematology. Innovations. Clinical Practice.

22 September 2023 Irkutsk, 15 Chkalov str. (Irkutsk City Center hotel), conference hall

E-platform: https://zoom.us/

11.00 – 11.10 – Opening of the conference. Welcome speech to the conference participants.

Moderators: V.G. Sturov, N.O. Saraeva.

11.10-11.30 – Anemias in women of reproductive age: perspective of a hematologist – V.G. Sturov (Novosibirsk).

11.30-11.50 – ITP: new treatment approaches  – N.O. Saraeva  (Irkutsk). Sponsor: Sobi. No “continuous medical education” points are granted.

11.50-12.10 – Assessment of the thrombogenic risk in children with essential arterial hypertension  – M.V. Gomellya (Irkutsk).  Sponsor: Irkutsk State Medical University.  No “continuous medical education” points are granted.

12.10-12.30 – Modern ways to treat PNH – E.A. Lukina (Moscow). Sponsor: Sobi. No “continuous medical education” points are granted.

12.30-12.50 – Experience of treating hemophilia A patients with Emicizumabum in the Irkutsk oblast – N.O. Saraeva (Irkutsk). Sponsor: Roche. No “continuous medical education” points are granted.

12.50-13.10 – Monoclonal gammopathy of renal significance – G.M. Orlova (Irkutsk). Sponsor: Irkutsk State Medical University.  No “continuous medical education” points are granted.

13.10 – 13.30 – Coffee break.

Moderators: G.M. Orlova, N.O. Saraeva.

13.30-13.50 – A breakthrough in treatment of recurrent/refractory multiple myeloma. New combinations, new effectiveness. – S.V. Syomochkin (Moscow). Sponsor: JSC R-Farm. No “continuous medical education” points are granted.

13.50-14.10 – Current approaches to fixed-term therapy of CLL. – E.A. Nikitin (Moscow).

14.10-14.30 – CLL therapy in clinical studies and real clinical practice. – E.A. Nikitin (Moscow). Sponsor: Janssen. No “continuous medical education” points are granted.

14.30-14.50 – CLL treatment: criticality of loosing no time.  – E.A. Stadnik (Saint-Petersburg).  Sponsor: AstraZeneca. No “continuous medical education” points are granted.

14.50-15.10 – Case study of CLL therapy: a comorbid patient.– E.I. Sbitnyakova (Saint-Petersburg).  Sponsor: AstraZeneca. No “continuous medical education” points are granted.

15.10-15.30 – Use of Daratumumab in the first line therapy of multiple myeloma. Experience of Hemablastose Chemotheraphy Department, N.N. Blokhin Nantional Medical Research Center, Russian Ministry of Healthcare.  – A.A. Semyonova (Moscow). Sponsor: Janssen. No “continuous medical education” points are granted.

15.30-15.50 – Thrombophilias and pregnancy: current perspective of the problem – T.N. Zaguzina (Prague, Czech Republic).

15.50-16.10 – Innovative approaches to treatment of polycythemia vera – E.V. Morozova (Saint-Petersburg).

16.10-16.30 – Incidence and mortality rates of lymph and blood malignancies in the Irkutsk oblast – N.R. Solovkova (Irkutsk). Sponsor: Irkutsk State Medical University.  No “continuous medical education” points are granted.

16.30 – 16.40 – Discussion.

Speakers

Viktor Gennadievich Sturov,
Doctor of Medicine,
Professor of V. Zelman Medicine and Pshychology Institute,
Novosibirsk National Research University
(Novosibirsk)

Natalia Orestovna Saraeva, Doctor of Medicine, Chief Hematologist of
Irkutsk Oblast Ministry of Healthcare, Deputy Medical Superintendent for Therapeutics of the Irkutsk Oblast Clinical Hospital – bearer of the Badge of Honor, Professor of the Hospital Therapy Chair, Irkutsk State Medical University, Russian Ministry of Healthcare (Irkutsk)

Viktor Gennadievich Sturov,
Doctor of Medicine, Professor of V. Zelman Medicine and Pshychology Institute, Novosibirsk National Research University
(Novosibirsk)

Natalia Orestovna Saraeva, Doctor of Medicine, Chief Hematologist of
Irkutsk Oblast Ministry of Healthcare, Deputy Medical Superintendent for Therapeutics of the Irkutsk Oblast Clinical Hospital – bearer of the Badge of Honor, Professor of the Hospital Therapy Chair, Irkutsk State Medical University, Russian Ministry of Healthcare (Irkutsk)

Marina Vladimirovna Gomellya, Doctor of Medicine, Professor of Child Diseases and Infections Chair, Irkutsk State Medical University, Russian Ministry of Healthcare (Irkutsk)

Tamara Semyonovna Krupskaya, 
Vice-Rector for International and Foreign Student Relations, M.D., PhD, Head of the Childhood Diseases and Infections Department, Irkutsk State Medical University (Irkutsk)

Marina Vladimirovna Gomellya,
Doctor of Medicine, Professor of Child Diseases and Infections Chair, Irkutsk State Medical University, Russian Ministry of Healthcare
(Irkutsk)

Tamara Semyonovna Krupskaya, 
Vice-Rector for International and Foreign Student Relations, M.D., PhD, Head of the Childhood Diseases and Infections Department, Irkutsk State Medical University
(Irkutsk)

Sergey Vyacheslavovich Syomochkin,
Doctor of Medicine, Head of High-Dose Chemotherapy and Bone Marrow Transplantation Group, P.A. Gertsen Moscow Oncology Research Institute, National Medical Research Center for Radiology, Russian Ministry of Healthcare (Moscow)

Maxim V. Soloviev,
head Department of Intensive High-Dose Chemotherapy of Paraproteinemic Hemoblastoses,
Candidate of Medical Sciences, National Medical Research Center of Hematology,
Moscow

Sergey Vyacheslavovich Syomochkin, Doctor of Medicine, Head of High-Dose Chemotherapy and Bone Marrow Transplantation Group, P.A. Gertsen Moscow Oncology Research Institute, National Medical Research Center for Radiology, Russian Ministry of Healthcare (Moscow)

Elena Alekseevna Lukina, Doctor of Medicine, Professor, Head of Orphan Disease Department, National Research Center for Hematology
(Moscow)

Elena Aleksandrovna Stadnik, Candidate of Medicine, Associate Professor of Research Oriented Therapy Chair, I.P. Pavlov Saint-Petersburg State Medical University; Head of Hematology and Oncology Department,
Consulting and Diagnostics Center,
Clinic of V.A. Almazov National Medical Research Center, Russian Ministry of Healthcare
(Saint-Petersburg)

Evgeny Aleksandrovich Nikitin, Doctor of Medicine, Professor, Head of Hematology and Transfusiology Chair named after the academicians I.A. Kassirsky and A.I. Vorobiyov, Russian Medical Academy of Continuous Professional Training, Russian Ministry of Healthcare; Head of Daytime Patient Department of Hematology, Oncology and Chemotherapy, Moscow Hematology Center, S.P. Botkin Moscow Clinical Hospital (Moscow)

Elena Aleksandrovna Stadnik,
Candidate of Medicine, Associate Professor of Research Oriented Therapy Chair, I.P. Pavlov Saint-Petersburg State Medical University; Head of Hematology and Oncology Department, Consulting and Diagnostics Center, Clinic of V.A. Almazov National Medical Research Center, Russian Ministry of Healthcare (Saint-Petersburg)

Evgeny Aleksandrovich Nikitin, Doctor of Medicine, Professor, Head of Hematology and Transfusiology Chair named after the academicians I.A. Kassirsky and A.I. Vorobiyov, Russian Medical Academy of Continuous Professional Training, Russian Ministry of Healthcare; Head of Daytime Patient Department of Hematology, Oncology and Chemotherapy, Moscow Hematology Center, S.P. Botkin Moscow Clinical Hospital (Moscow)

Galina Mikhailovna Orlova,
Doctor of Medicine, Professor of Hospital Therapy Chair,
Irkutsk State Medical University, Russian Ministry of Healthcare
(Irkutsk)

Elena Vladislavovna Morozova,
Candidate of Medicine, Associate Professor, Head of Juvenile and Adult Oncology, Hematology and Transplantology Department, R.M. Gorbachyova Research Institute of Pediatric Oncology, Hematoloty and Transplantology, I.P. Pavlov Saint-Petersburg State Medical University, Russian Ministry of Healthcare (Saint-Petersburg)

Galina Mikhailovna Orlova,
Doctor of Medicine, Professor of Hospital Therapy Chair,
Irkutsk State Medical University, Russian Ministry of Healthcare
(Irkutsk)

Elena Vladislavovna Morozova, Candidate of Medicine, Associate Professor, Head of Juvenile and Adult Oncology, Hematology and Transplantology Department, R.M. Gorbachyova Research Institute of Pediatric Oncology, Hematoloty and Transplantology, I.P. Pavlov Saint-Petersburg State Medical University, Russian Ministry of Healthcare (Saint-Petersburg)

Evgeniya Igorevna Sbitnyakova, Hematologist of the Department of Specialized Medical Aid to Oncological Patients, V.A. Almazov National Medical Research Center, Russian Ministry of Healthcare
(Saint-Petersburg)

Nataliya Rafailovna Solovkova,
Hematologist of Chemotheraphy Office, Irkutsk Oblast Clinical Hospital – bearer of the Badge of Honor
(Irkutsk)

Evgeniya Igorevna Sbitnyakova, Hematologist of the Department of Specialized Medical Aid to Oncological Patients, V.A. Almazov National Medical Research Center, Russian Ministry of Healthcare
(Saint-Petersburg)

Nataliya Rafailovna Solovkova,
Hematologist of Chemotheraphy Office, Irkutsk Oblast Clinical Hospital – bearer of the Badge of Honor
(Irkutsk)

Zaguzina Tatiana Nikolaevna,
doctoral student (Charles University, First Faculty of Medicine, Prague, Czech Republic),
hematologist (Department of Clinical Hematology and Transfusion, University Hospital Bulovka, Prague, Czech Republic)
EHA member

Zaguzina Tatiana Nikolaevna,
doctoral student (Charles University, First Faculty of Medicine, Prague, Czech Republic),
hematologist (Department of Clinical Hematology and Transfusion, University Hospital Bulovka, Prague, Czech Republic)
EHA member

Organized by

Sponsored by

Partners

Previous agendas